← Back to Search

Cell Therapy

There are no disallowed treatments for HIV

Phase 1
Waitlist Available
Research Sponsored by Sangamo Therapeutics
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Subjects who have, in previous Sangamo clinical trial received SB-728-T or SB-728mR-T, autologous T-cells genetically modified at the CCR5 gene by zinc finger nucleases and give consent to participate in the long-term follow-up study.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 years
Awards & highlights

Study Summary

This trial will follow HIV-infected subjects who received either SB-728-T or SB-728mR-T in a previous trial for a total of 12 years.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Long-term safety of treatment with SB-728-T or SB-728mR-T
Secondary outcome measures
Long-term effects of SB-728-T or SB-728mR-T on CD4+ T-cell counts and on the viral load and tropism of HIV in blood.
Other outcome measures
Change in HIV reservoirs

Trial Design

1Treatment groups
Experimental Treatment
Group I: Cohort 1Experimental Treatment1 Intervention
Long-term follow-up of HIV-infected subjects who received SB-728-T or SB-728mR-T in a previous trial.

Find a Location

Who is running the clinical trial?

Sangamo TherapeuticsLead Sponsor
28 Previous Clinical Trials
911 Total Patients Enrolled
Medical MonitorStudy DirectorSangamo Therapeutics, Inc.
1,649 Previous Clinical Trials
979,687 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Long-term Follow-up of HIV Subjects Exposed to SB-728-T or SB-728mR-T
2011. "Long-term Follow-up of HIV Subjects Exposed to SB-728-T or SB-728mR-T". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04201782.
~3 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top